EMA Authorised: Ledaga (chlormethine) — Helsinn Birex Pharmaceuticals Ltd.

View source ↗

Summary

The European Medicines Agency authorised Ledaga (chlormethine) for the treatment of mycosis fungoides, with orphan designation noted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides

Drugs mentioned

• Ledaga (chlormethine)

Snippet

Status: Authorised. Therapeutic area: Mycosis Fungoides. MAH: Helsinn Birex Pharmaceuticals Ltd.. Decision date: 11/12/2024. Orphan medicine